New appointment at Catalyst Biosciences
This article was originally published in Scrip
Executive Summary
Catalyst Biosciences, a US company focused on the discovery and development of engineered proteases known as Alterase therapeutics, has named William Dawson chief financial officer. He has more than 30 years' financial management and business development experience, having previously served as vice-president of finance and chief financial officer at Cerus.